{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:01:59Z","timestamp":1793311319904,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recent evidence links gut dysbiosis and the gut-brain axis to the pathophysiology of Parkinson\u2019s disease (PD), which is considered one of the most common neurodegenerative illnesses and is characterized by motor symptoms and a gradual loss of nigral dopaminergic neurons. Canagliflozin (CANA), a sodium\u2013glucose cotransporter-2 inhibitor with emerging anti-inflammatory and antioxidant properties, has recently gained attention for its neuroprotective effects beyond glycemic control. This research aimed to examine the neuroprotective potential of CANA in a rat model of PD, focusing on its potential effect on the gut-inflammasome\u2013brain axis. Rats were treated with rotenone\u00a0(ROT) (2\u00a0mg\/kg, subcutaneous) and\/or CANA (20\u00a0mg\/kg, oral) for 30 consecutive days. Behavioral assessment (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200913), biochemical assays (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20096), and histological and immunohistochemical analysis (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20093) were performed. Microbiome profiling (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20093)  using 16S rRNA amplicon sequencing was conducted using three pooled fecal samples\/group, with each pool prepared from fecal material collected from three rats and fecal metabolomic profiling (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20095) was performed to assess microbial metabolites. ROT intoxication caused significant motor impairments, including decreased locomotor activity, poor coordination, and increased catalepsy. Further histological examination demonstrated dopaminergic neuronal loss and \u03b1-synuclein aggregation in the substantia nigra and striatum. CANA treatment enhanced motor function, conserved neuronal integrity, and decreased \u03b1-synuclein accumulation. Moreover, ROT altered the gut microbiota with selective taxonomic shifts, including enriched abundance of\n                    <jats:italic>Parabacteroides<\/jats:italic>\n                    and\n                    <jats:italic>Ruminococcaceae<\/jats:italic>\n                    with depleted\n                    <jats:italic>Prevotella<\/jats:italic>\n                    -related taxa, in addition to fecal metabolite profile alteration. Consequently, it increased colonic oxidative stress and weakened tight junctions, all of which enhanced LPS translocation. This systemic endotoxemia generated oxidative stress, dyslipidemia, and NF-\u03baB\/NLRP3 inflammasome activation. Conversely, CANA restored gut microbial balance and their metabolites, and gut integrity, decreased LPS leakage, and reduced systemic and central oxidative stress and inflammation, preventing inflammasome activation and \u03b1-synuclein aggregation. Collectively, these findings suggest that CANA may exert neuroprotective effects in ROT-induced PD associated with modulating the gut-inflammasome\u2013brain axis.\n                  <\/jats:p>","DOI":"10.1007\/s10787-026-02292-5","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:57:24Z","timestamp":1782111444000},"page":"4753-4782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Canagliflozin attenuates Parkinson\u2019s disease and is associated with modulation of gut-inflammasome\u2013brain axis in rats"],"prefix":"10.1007","volume":"34","author":[{"given":"Nada K.","family":"Gamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik","family":"Fakhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youmna","family":"Hatem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Marzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K. M.","family":"Bukr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerolos","family":"Safwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mamdouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"AbdElFatah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iriny M.","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina Y.","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"5","key":"2292_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jnc.13087","volume":"133","author":"RM Abdelsalam","year":"2015","unstructured":"Abdelsalam RM, Safar MM (2015) Neuroprotective effects of vildagliptin in rat rotenone Parkinson\u2019s disease model: role of RAGE-NFkappaB and Nrf2-antioxidant signaling pathways. J Neurochem 133(5):700\u2013707. https:\/\/doi.org\/10.1111\/jnc.13087","journal-title":"J Neurochem"},{"key":"2292_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126. https:\/\/doi.org\/10.1016\/s0076-6879(84)05016-3","journal-title":"Methods Enzymol"},{"key":"2292_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1738871","author":"KM Aldossary","year":"2026","unstructured":"Aldossary KM, Hamza E, Kamel MM et al (2026) Interplay of oxidative stress and Inflammasome activation and clinical indices in Parkinson\u2019s disease: insights from serum SIRT1, Nrf2, and NLRP3 levels and PDQ-39\u2014a cross-sectional study. Front NeuroSci. https:\/\/doi.org\/10.3389\/fnins.2025.1738871","journal-title":"Front NeuroSci"},{"key":"2292_CR4","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1016\/B978-0-443-10279-0.50004-X","volume-title":"Theory and Practice of Histological Techniques (Sixth Edition)","author":"JD Bancroft","year":"2008","unstructured":"Bancroft JD, Gamble M (2008) Preface to the sixth edition. In: Bancroft JD, Gamble M (eds) Theory and practice of histological techniques (Sixth Edition). Churchill Livingstone, Edinburgh, p ix"},{"issue":"1","key":"2292_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR, Hildebrand F, Coelho LP et al (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 9(1):39\u201339. https:\/\/doi.org\/10.1186\/s13073-017-0428-y","journal-title":"Genome Med"},{"key":"2292_CR6","first-page":"882","volume":"61","author":"E Beutler","year":"1963","unstructured":"Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882\u2013888","journal-title":"J Lab Clin Med"},{"issue":"8","key":"2292_CR7","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/ismej.2012.8","volume":"6","author":"JG Caporaso","year":"2012","unstructured":"Caporaso JG, Lauber CL, Walters WA et al (2012) Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6(8):1621\u20131624. https:\/\/doi.org\/10.1038\/ismej.2012.8","journal-title":"ISME J"},{"issue":"2","key":"2292_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1570159x14666151204122017","volume":"14","author":"MN Catorce","year":"2016","unstructured":"Catorce MN, Gevorkian G (2016) LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals. Curr Neuropharmacol 14(2):155\u2013164. https:\/\/doi.org\/10.2174\/1570159x14666151204122017","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"2292_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.bbi.2007.08.014","volume":"22","author":"J Chen","year":"2008","unstructured":"Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW (2008) Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun 22(3):301\u2013311. https:\/\/doi.org\/10.1016\/j.bbi.2007.08.014","journal-title":"Brain Behav Immun"},{"issue":"7","key":"2292_CR10","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea MS, Yu AC, Golz E et al (2020) Microbiota Composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov Disord 35(7):1208\u20131217. https:\/\/doi.org\/10.1002\/mds.28052","journal-title":"Mov Disord"},{"key":"2292_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.01041","author":"A Cosma-Grigorov","year":"2020","unstructured":"Cosma-Grigorov A, Meixner H, Mrochen A, Wirtz S, Winkler J, Marxreiter F (2020) Changes in gastrointestinal microbiome composition in PD: a pivotal role of covariates. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.01041","journal-title":"Front Neurol"},{"key":"2292_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00431-23","author":"C Cui","year":"2023","unstructured":"Cui C, Song H, Han Y et al (2023) Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson\u2019s disease. mSphere. https:\/\/doi.org\/10.1128\/msphere.00431-23","journal-title":"MSphere"},{"issue":"2","key":"2292_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jaccao.2024.01.007","volume":"6","author":"MS Dabour","year":"2024","unstructured":"Dabour MS, George MY, Daniel MR, Blaes AH, Zordoky BN (2024) The cardioprotective and anticancer effects of SGLT2 inhibitors: JACC: cardiooncology state-of-the-art review. JACC CardioOncol 6(2):159\u2013182. https:\/\/doi.org\/10.1016\/j.jaccao.2024.01.007","journal-title":"JACC CardioOncol"},{"issue":"2","key":"2292_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00204-024-03913-0","volume":"99","author":"MS Dabour","year":"2025","unstructured":"Dabour MS, George MY, Grant MKO, Zordoky BN (2025) Canagliflozin differentially modulates carfilzomib-induced endoplasmic reticulum stress in multiple myeloma and endothelial cells. Arch Toxicol 99(2):729\u2013744. https:\/\/doi.org\/10.1007\/s00204-024-03913-0","journal-title":"Arch Toxicol"},{"issue":"2","key":"2292_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/microorganisms14020290","volume":"14","author":"DA De Salles","year":"2026","unstructured":"De Salles DA, Prajapati CB, Yadav SKD et al (2026) Probiotic and dietary supplements intervention in age-related neurodegenerative disorders. Microorganisms 14(2):290. https:\/\/doi.org\/10.3390\/microorganisms14020290","journal-title":"Microorganisms"},{"key":"2292_CR16","doi-asserted-by":"publisher","first-page":"110491","DOI":"10.1016\/j.cbi.2023.110491","volume":"379","author":"MA Desouky","year":"2023","unstructured":"Desouky MA, George MY, Michel HE, Elsherbiny DA (2023b) Roflumilast escalates \u03b1-synuclein aggregate degradation in rotenone-induced Parkinson\u2019s disease in rats: modulation of the ubiquitin-proteasome system and endoplasmic reticulum stress. Chemico-Biol Interact 379:110491. https:\/\/doi.org\/10.1016\/j.cbi.2023.110491","journal-title":"Chemico-Biol Interact"},{"key":"2292_CR17","doi-asserted-by":"publisher","first-page":"123206","DOI":"10.1016\/j.lfs.2024.123206","volume":"359","author":"MA Desouky","year":"2024","unstructured":"Desouky MA, Michel HE, Elsherbiny DA, George MY (2024) Recent pharmacological insights on abating toxic protein species burden in neurological disorders: emphasis on 26S proteasome activation. Life Sci 359:123206. https:\/\/doi.org\/10.1016\/j.lfs.2024.123206","journal-title":"Life Sci"},{"issue":"3","key":"2292_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s0169-409x(00)00049-1","volume":"41","author":"HA Edens","year":"2000","unstructured":"Edens HA, Parkos CA (2000) Modulation of epithelial and endothelial paracellular permeability by leukocytes. Adv Drug Deliv Rev 41(3):315\u2013328. https:\/\/doi.org\/10.1016\/s0169-409x(00)00049-1","journal-title":"Adv Drug Deliv Rev"},{"issue":"16","key":"2292_CR19","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","volume":"27","author":"RC Edgar","year":"2011","unstructured":"Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R (2011) UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27(16):2194\u20132200. https:\/\/doi.org\/10.1093\/bioinformatics\/btr381","journal-title":"Bioinformatics"},{"key":"2292_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120392","author":"EA Elhawary","year":"2025","unstructured":"Elhawary EA, George MY, Sabry NC, Ayoub IM, Nasr M, Youssef FS (2025) Tectona grandis metabolites alleviate oxaliplatin-induced chemofog in rats: modulation of the NLRP3 inflammasome axis. J Ethnopharmacol. https:\/\/doi.org\/10.1016\/j.jep.2025.120392","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"2292_CR21","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.4103\/1673-5374.391191","volume":"19","author":"X Fang","year":"2024","unstructured":"Fang X, Liu S, Muhammad B et al (2024) Gut microbiota dysbiosis contributes to \u03b1-synuclein-related pathology associated with C\/EBP\u03b2\/AEP signaling activation in a mouse model of Parkinson\u2019s disease. Neural Regeneration Res 19(9):2081\u20132088. https:\/\/doi.org\/10.4103\/1673-5374.391191","journal-title":"Neural Regeneration Res"},{"key":"2292_CR22","doi-asserted-by":"publisher","first-page":"111354","DOI":"10.1016\/j.intimp.2023.111354","volume":"127","author":"SF Fawzi","year":"2024","unstructured":"Fawzi SF, Michel HE, Menze ET, Tadros MG, George MY (2024) Clotrimazole ameliorates chronic mild stress-induced depressive-like behavior in rats; crosstalk between the HPA, NLRP3 inflammasome, and Wnt\/beta-catenin pathways. Int Immunopharmacol 127:111354. https:\/\/doi.org\/10.1016\/j.intimp.2023.111354","journal-title":"Int Immunopharmacol"},{"key":"2292_CR23","doi-asserted-by":"publisher","first-page":"114216","DOI":"10.1016\/j.intimp.2025.114216","volume":"149","author":"NK Gamal","year":"2025","unstructured":"Gamal NK, El-Naga RN, Ayoub IM, George MY (2025) Neuromodulatory effect of troxerutin against doxorubicin and cyclophosphamide-induced cognitive impairment in rats: potential crosstalk between gut-brain and NLRP3 inflammasome axes. Int Immunopharmacol 149:114216. https:\/\/doi.org\/10.1016\/j.intimp.2025.114216","journal-title":"Int Immunopharmacol"},{"key":"2292_CR24","doi-asserted-by":"publisher","unstructured":"Gamal NK, Fakhry R, Hatem Y et al (2026) Neurodegeneration at the crossroads: the gut-brain axis and blood-brain barrier in Parkinson\u2019s disease \u2014 a review. 17:1813134. https:\/\/doi.org\/10.3389\/fphar.2026.1813134","DOI":"10.3389\/fphar.2026.1813134"},{"issue":"7","key":"2292_CR25","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/ddr.21800","volume":"82","author":"MY George","year":"2021","unstructured":"George MY, Menze ET, Esmat A, Tadros MG, El-Demerdash E (2021) Naringin treatment improved main clozapine-induced adverse effects in rats; emphasis on weight gain, metabolic abnormalities, and agranulocytosis. Drug Dev Res 82(7):980\u2013989. https:\/\/doi.org\/10.1002\/ddr.21800","journal-title":"Drug Dev Res"},{"issue":"6","key":"2292_CR26","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3390\/antiox13060671","volume":"13","author":"MY George","year":"2024","unstructured":"George MY, Dabour MS, Rashad E, Zordoky BN (2024) Empagliflozin alleviates carfilzomib-induced cardiotoxicity in mice by modulating oxidative stress, inflammatory response, endoplasmic reticulum stress, and autophagy. Antioxid (Basel) 13(6):671. https:\/\/doi.org\/10.3390\/antiox13060671","journal-title":"Antioxid (Basel)"},{"issue":"6","key":"2292_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/hematolrep17060056","volume":"17","author":"MY George","year":"2025","unstructured":"George MY, Gamal NK, Mansour DE et al (2025) The gut microbiome role in multiple myeloma: emerging insights and therapeutic opportunities. Hematol Rep 17(6):56. https:\/\/doi.org\/10.3390\/hematolrep17060056","journal-title":"Hematol Rep"},{"issue":"1","key":"2292_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/medsci14010022","volume":"14","author":"MY George","year":"2026","unstructured":"George MY, Gamal NK, Safwat K et al (2026) From glucose transport to microbial modulation: the impact of sodium glucose co-transporter-2 inhibitors on the gut microbiota. Med Sci (Basel) 14(1):22. https:\/\/doi.org\/10.3390\/medsci14010022","journal-title":"Med Sci (Basel)"},{"key":"2292_CR29","doi-asserted-by":"publisher","first-page":"106000","DOI":"10.1016\/j.parkreldis.2024.106000","volume":"120","author":"N Grotewold","year":"2024","unstructured":"Grotewold N, Albin RL (2024) Update: Descriptive epidemiology of Parkinson disease. Parkinsonism Relat Disord 120:106000. https:\/\/doi.org\/10.1016\/j.parkreldis.2024.106000","journal-title":"Parkinsonism Relat Disord"},{"key":"2292_CR30","doi-asserted-by":"publisher","first-page":"174573","DOI":"10.1016\/j.ejphar.2021.174573","volume":"914","author":"CN Habib","year":"2022","unstructured":"Habib CN, Mohamed MR, Tadros MG, Tolba MF, Menze ET, Masoud SI (2022) The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson\u2019s disease in rats. Eur J Pharmacol 914:174573\u2013174573. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174573","journal-title":"Eur J Pharmacol"},{"key":"2292_CR31","doi-asserted-by":"publisher","first-page":"122245","DOI":"10.1016\/j.lfs.2023.122245","volume":"335","author":"CN Habib","year":"2023","unstructured":"Habib CN, Ali AE, Anber NH, George MY (2023) Lactoferrin ameliorates carfilzomib-induced renal and pulmonary deficits: Insights to the inflammasome NLRP3\/NF-kappaB and PI3K\/Akt\/GSK-3beta\/MAPK axes. Life Sci 335:122245. https:\/\/doi.org\/10.1016\/j.lfs.2023.122245","journal-title":"Life Sci"},{"key":"2292_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2300314","author":"L He","year":"2024","unstructured":"He L, Zuo Q, Ma S et al (2024) Canagliflozin attenuates kidney injury, gut-derived toxins, and gut microbiota imbalance in high-salt diet-fed Dahl salt-sensitive rats. Ren Fail. https:\/\/doi.org\/10.1080\/0886022X.2023.2300314","journal-title":"Ren Fail"},{"issue":"2","key":"2292_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells9020376","volume":"9","author":"T Hegelmaier","year":"2020","unstructured":"Hegelmaier T, Lebbing M, Duscha A et al (2020) Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson\u2019s disease. Cells 9(2):376\u2013376. https:\/\/doi.org\/10.3390\/cells9020376","journal-title":"Cells"},{"issue":"5","key":"2292_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT et al (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u2013749. https:\/\/doi.org\/10.1002\/mds.26942","journal-title":"Mov Disord"},{"key":"2292_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","volume":"1667","author":"F Hopfner","year":"2017","unstructured":"Hopfner F, K\u00fcnstner A, M\u00fcller SH et al (2017) Gut microbiota in Parkinson disease in a northern German cohort. Brain Res 1667:41\u201345. https:\/\/doi.org\/10.1016\/j.brainres.2017.04.019","journal-title":"Brain Res"},{"key":"2292_CR36","doi-asserted-by":"publisher","first-page":"108738","DOI":"10.1016\/j.neuropharm.2021.108738","volume":"197","author":"SS Ibrahim","year":"2021","unstructured":"Ibrahim SS, Abo Elseoud OG, Mohamedy MH et al (2021) Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: insights on formulation, oxidative stress and TLR4\/NF-kB\/NLRP3 pathways. Neuropharmacology 197:108738. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108738","journal-title":"Neuropharmacology"},{"key":"2292_CR37","doi-asserted-by":"publisher","first-page":"147958","DOI":"10.1016\/j.brainres.2022.147958","volume":"1789","author":"IO Ishola","year":"2022","unstructured":"Ishola IO, Awogbindin IO, Olubodun-Obadun TG, Oluwafemi OA, Onuelu JE, Adeyemi OO (2022) Morin ameliorates rotenone-induced Parkinson disease in mice through antioxidation and anti-neuroinflammation: gut-brain axis involvement. Brain Res 1789:147958\u2013147958. https:\/\/doi.org\/10.1016\/j.brainres.2022.147958","journal-title":"Brain Res"},{"key":"2292_CR38","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33939","author":"B Jasleen","year":"2023","unstructured":"Jasleen B, Vishal GK, Sameera M et al (2023) Sodium-glucose cotransporter 2 (SGLT2) inhibitors: benefits versus risk. Cureus https:\/\/doi.org\/10.7759\/cureus.33939","journal-title":"Cureus"},{"key":"2292_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","volume":"46","author":"ME Johnson","year":"2015","unstructured":"Johnson ME, Bobrovskaya L (2015) An update on the rotenone models of Parkinson\u2019s disease: their ability to reproduce the features of clinical disease and model gene\u2013environment interactions. Neurotoxicology 46:101\u2013116. https:\/\/doi.org\/10.1016\/j.neuro.2014.12.002","journal-title":"Neurotoxicology"},{"issue":"10","key":"2292_CR40","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA et al (2015) Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 30(10):1351\u20131360. https:\/\/doi.org\/10.1002\/mds.26307","journal-title":"Mov Disord"},{"key":"2292_CR41","doi-asserted-by":"publisher","first-page":"782082","DOI":"10.3389\/fnagi.2021.782082","volume":"13","author":"EM Klann","year":"2022","unstructured":"Klann EM, Dissanayake U, Gurrala A et al (2022) The gut\u2013brain axis and its relation to Parkinson\u2019s disease: a review. Front Aging Neurosci 13:782082. https:\/\/doi.org\/10.3389\/fnagi.2021.782082","journal-title":"Front Aging Neurosci"},{"issue":"17","key":"2292_CR42","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1128\/AEM.01043-13","volume":"79","author":"JJ Kozich","year":"2013","unstructured":"Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD (2013) Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq illumina sequencing platform. Appl Environ Microbiol 79(17):5112\u20135120. https:\/\/doi.org\/10.1128\/AEM.01043-13.\u00a0","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"2292_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1124\/jpet.114.217992","volume":"351","author":"C Kuriyama","year":"2014","unstructured":"Kuriyama C, Xu JZ, Lee SP et al (2014) Analysis of the effect of canagliflozin on renal glucose reabsorption and progression of hyperglycemia in Zucker Diabetic Fatty Rats. J Pharmacol Exp Ther 351(2):423\u2013431. https:\/\/doi.org\/10.1124\/jpet.114.217992","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2292_CR44","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1007\/s12035-018-1334-z","volume":"56","author":"A Kurtishi","year":"2019","unstructured":"Kurtishi A, Rosen B, Patil KS, Alves GW, M\u00f8ller SG (2019) Cellular proteostasis in neurodegeneration. Mol Neurobiol 56(5):3676\u20133689. https:\/\/doi.org\/10.1007\/s12035-018-1334-z","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2292_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/biomedicines12010036","volume":"12","author":"C-T Lee","year":"2023","unstructured":"Lee C-T, Lin K-D, Hsieh C-F, Wang J-Y (2023) SGLT2 inhibitor canagliflozin alleviates high glucose-induced inflammatory toxicity in BV-2 microglia. Biomedicines 12(1):36\u201336. https:\/\/doi.org\/10.3390\/biomedicines12010036","journal-title":"Biomedicines"},{"issue":"1","key":"2292_CR46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12974-020-01940-z","volume":"17","author":"N Li","year":"2020","unstructured":"Li N, Stewart T, Sheng L et al (2020) Immunoregulation of microglial polarization: an unrecognized physiological function of \u03b1-synuclein. J Neuroinflamm 17(1):272\u2013272. https:\/\/doi.org\/10.1186\/s12974-020-01940-z","journal-title":"J Neuroinflamm"},{"key":"2292_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1185375","author":"Q Li","year":"2023","unstructured":"Li Q, Meng L-b, Chen L-j et al (2023) The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson\u2019s disease. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2023.1185375","journal-title":"Front Neurol"},{"issue":"19","key":"2292_CR48","doi-asserted-by":"publisher","first-page":"9593","DOI":"10.3390\/ijms26199593","volume":"26","author":"Y Liang","year":"2025","unstructured":"Liang Y, Zhao Y, Fasano A, Su C-W (2025) Gut permeability and microbiota in parkinson\u2019s disease: mechanistic insights and experimental therapeutic strategies. Int J Mol Sci 26(19):9593\u20139593. https:\/\/doi.org\/10.3390\/ijms26199593","journal-title":"Int J Mol Sci"},{"key":"2292_CR49","doi-asserted-by":"publisher","first-page":"115426","DOI":"10.1016\/j.bbr.2025.115426","volume":"482","author":"J Liao","year":"2025","unstructured":"Liao J, Jiang L, Qin Y, Hu J, Tang Z (2025) Causal association between cerebrospinal fluid metabolites and Parkinson\u2019s disease: a two-sample bidirectional mendelian randomization study. Behav Brain Res 482:115426. https:\/\/doi.org\/10.1016\/j.bbr.2025.115426","journal-title":"Behav Brain Res"},{"key":"2292_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bbr.2015.07.058","volume":"294","author":"Y Liu","year":"2015","unstructured":"Liu Y, Sun J-D, Song L-K et al (2015) Environment-contact administration of rotenone: a new rodent model of Parkinson\u2019s disease. Behav Brain Res 294:149\u2013161. https:\/\/doi.org\/10.1016\/j.bbr.2015.07.058","journal-title":"Behav Brain Res"},{"key":"2292_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyw047","author":"M Lu","year":"2016","unstructured":"Lu M, Su C, Qiao C, Bian Y, Ding J, Hu G (2016) Metformin prevents dopaminergic neuron death in MPTP\/P-induced mouse model of Parkinson\u2019s disease via autophagy and mitochondrial ROS clearance. Int J Neuropsychopharmacol. https:\/\/doi.org\/10.1093\/ijnp\/pyw047","journal-title":"Int J Neuropsychopharmacol"},{"issue":"W1","key":"2292_CR52","doi-asserted-by":"publisher","first-page":"W310","DOI":"10.1093\/nar\/gkad407","volume":"51","author":"Y Lu","year":"2023","unstructured":"Lu Y, Zhou G, Ewald J, Pang Z, Shiri T, Xia J (2023) MicrobiomeAnalyst 2.0: comprehensive statistical, functional and integrative analysis of microbiome data. Nucleic Acids Res 51(W1):W310\u2013W318. https:\/\/doi.org\/10.1093\/nar\/gkad407","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2292_CR53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10157-022-02312-y","volume":"27","author":"A Matsui","year":"2023","unstructured":"Matsui A, Yoshifuji A, Irie J et al (2023) Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized rats. Clin Exp Nephrol 27(4):295\u2013308. https:\/\/doi.org\/10.1007\/s10157-022-02312-y","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2292_CR54","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10787-023-01384-w","volume":"32","author":"NN Mohammed","year":"2024","unstructured":"Mohammed NN, Tadros MG, George MY (2024) Empagliflozin repurposing in Parkinson\u2019s disease; modulation of oxidative stress, neuroinflammation, AMPK\/SIRT-1\/PGC-1alpha, and wnt\/beta-catenin pathways. Inflammopharmacology 32(1):777\u2013794. https:\/\/doi.org\/10.1007\/s10787-023-01384-w","journal-title":"Inflammopharmacology"},{"issue":"21","key":"2292_CR55","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.3390\/molecules27217174","volume":"27","author":"MM Nakhal","year":"2022","unstructured":"Nakhal MM, Aburuz S, Sadek B, Akour A (2022) Repurposing SGLT2 inhibitors for neurological disorders: a focus on the autism spectrum disorder. Molecules 27(21):7174\u20137174. https:\/\/doi.org\/10.3390\/molecules27217174","journal-title":"Molecules"},{"issue":"3","key":"2292_CR56","doi-asserted-by":"publisher","first-page":"e58403","DOI":"10.1371\/journal.pone.0058403","volume":"8","author":"KA Neely","year":"2013","unstructured":"Neely KA, Planetta PJ, Prodoehl J et al (2013) Force control deficits in individuals with parkinson\u2019s disease, multiple systems atrophy, and progressive supranuclear palsy. PLoS ONE 8(3):e58403\u2013e58403. https:\/\/doi.org\/10.1371\/journal.pone.0058403","journal-title":"PLoS ONE"},{"key":"2292_CR57","doi-asserted-by":"publisher","first-page":"147609","DOI":"10.1016\/j.brainres.2021.147609","volume":"1769","author":"SD Nielsen","year":"2021","unstructured":"Nielsen SD, Pearson NM, Seidler K (2021) The link between the gut microbiota and Parkinson\u2019s Disease: a systematic mechanism review with focus on \u03b1-synuclein transport. Brain Res 1769:147609\u2013147609. https:\/\/doi.org\/10.1016\/j.brainres.2021.147609","journal-title":"Brain Res"},{"issue":"2","key":"2292_CR58","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0006-291X(72)80218-3","volume":"46","author":"M Nishikimi","year":"1972","unstructured":"Nishikimi M, Appaji Rao N, Yagi K (1972) The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 46(2):849\u2013854. https:\/\/doi.org\/10.1016\/S0006-291X(72)80218-3","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"2292_CR59","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/febs.12260","volume":"280","author":"P Pacher","year":"2013","unstructured":"Pacher P, Kunos G (2013) Modulating the endocannabinoid system in human health and disease\u2013successes and failures. FEBS J 280(9):1918\u20131943. https:\/\/doi.org\/10.1111\/febs.12260","journal-title":"FEBS J"},{"key":"2292_CR60","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","volume":"277","author":"SP Patil","year":"2014","unstructured":"Patil SP, Jain PD, Ghumatkar PJ, Tambe R, Sathaye S (2014) Neuroprotective effect of metformin in MPTP-induced Parkinson\u2019s disease in mice. Neuroscience 277:747\u2013754. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.07.046","journal-title":"Neuroscience"},{"issue":"23","key":"2292_CR61","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.3390\/molecules26237213","volume":"26","author":"A Pawlos","year":"2021","unstructured":"Pawlos A, Broncel M, Wo\u017aniak E, Gorzelak-Pabi\u015b P (2021) Neuroprotective effect of SGLT2 inhibitors. Molecules 26(23):7213\u20137213. https:\/\/doi.org\/10.3390\/molecules26237213","journal-title":"Molecules"},{"key":"2292_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1600148","author":"JM Pfaffinger","year":"2025","unstructured":"Pfaffinger JM, Hays KE, Seeley J, Ramesh Babu P, Ryznar R (2025) Gut dysbiosis as a potential driver of Parkinson\u2019s and Alzheimer\u2019s disease pathogenesis. Front NeuroSci. https:\/\/doi.org\/10.3389\/fnins.2025.1600148","journal-title":"Front NeuroSci"},{"issue":"1","key":"2292_CR63","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Disease Primers 3(1):17013\u201317013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Reviews Disease Primers"},{"issue":"4","key":"2292_CR64","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12640-016-9693-6","volume":"31","author":"SK Prajapati","year":"2017","unstructured":"Prajapati SK, Garabadu D, Krishnamurthy S (2017) Coenzyme Q10 prevents mitochondrial dysfunction and facilitates pharmacological activity of atorvastatin in 6-OHDA induced dopaminergic toxicity in rats. Neurotox Res 31(4):478\u2013492. https:\/\/doi.org\/10.1007\/s12640-016-9693-6","journal-title":"Neurotox Res"},{"key":"2292_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaf038","author":"SK Prajapati","year":"2025","unstructured":"Prajapati SK, Jain S, Yadav H (2025a) Age-related cognitive decline and dementia: interface of microbiome-immune-neuronal interactions. J Gerontol Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/gerona\/glaf038","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"1","key":"2292_CR66","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41598-024-84780-8","volume":"15","author":"SK Prajapati","year":"2025","unstructured":"Prajapati SK, Wang S, Mishra SP, Jain S, Yadav H (2025b) Protection of Alzheimer\u2019s disease progression by a human-origin probiotics cocktail. Sci Rep 15(1):1589. https:\/\/doi.org\/10.1038\/s41598-024-84780-8","journal-title":"Sci Rep"},{"key":"2292_CR67","doi-asserted-by":"publisher","first-page":"115089","DOI":"10.1016\/j.intimp.2025.115089","volume":"162","author":"J Quan","year":"2025","unstructured":"Quan J, Liu X, Liang S et al (2025) Electroacupuncture suppresses motor impairments via microbiota-metabolized LPS\/NLRP3 signaling in 6-OHDA induced Parkinson\u2019s disease rats. Int Immunopharmacol 162:115089\u2013115089. https:\/\/doi.org\/10.1016\/j.intimp.2025.115089","journal-title":"Int Immunopharmacol"},{"issue":"D1","key":"2292_CR68","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2012","unstructured":"Quast C, Pruesse E, Yilmaz P et al (2012) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41(D1):D590\u2013D596. https:\/\/doi.org\/10.1093\/nar\/gks1219","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2292_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-013-1199-5","volume":"39","author":"CD Rae","year":"2014","unstructured":"Rae CD (2014) A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem Res 39(1):1\u201336. https:\/\/doi.org\/10.1007\/s11064-013-1199-5","journal-title":"Neurochem Res"},{"key":"2292_CR70","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fneur.2020.00137","volume":"11","author":"T Ren","year":"2020","unstructured":"Ren T, Gao Y, Qiu Y et al (2020) Gut microbiota altered in mild cognitive impairment compared with normal cognition in sporadic Parkinson\u2019s disease. Front Neurol 11:137. https:\/\/doi.org\/10.3389\/fneur.2020.00137","journal-title":"Front Neurol"},{"issue":"3","key":"2292_CR71","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2174\/18715273113126660160","volume":"13","author":"S Rizvi","year":"2014","unstructured":"Rizvi S, Shakil S, Biswas D et al (2014) Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in alzheimer\u2019s disease- diabetes Type 2 linkage via an enzoinformatics study. CNS Neurol Disorders - Drug Targets 13(3):447\u2013451. https:\/\/doi.org\/10.2174\/18715273113126660160","journal-title":"CNS Neurol Disorders - Drug Targets"},{"issue":"1","key":"2292_CR72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0009-8981(78)90081-5","volume":"90","author":"K Satoh","year":"1978","unstructured":"Satoh K (1978) Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 90(1):37\u201343. https:\/\/doi.org\/10.1016\/0009-8981(78)90081-5","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2292_CR73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA et al (2015) Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30(3):350\u2013358. https:\/\/doi.org\/10.1002\/mds.26069","journal-title":"Mov Disord"},{"issue":"23","key":"2292_CR74","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","volume":"75","author":"PD Schloss","year":"2009","unstructured":"Schloss PD, Westcott SL, Ryabin T et al (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75(23):7537\u20137541. https:\/\/doi.org\/10.1128\/AEM.01541-09","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"2292_CR75","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L et al (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12(6):R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60","journal-title":"Genome Biol"},{"key":"2292_CR76","doi-asserted-by":"publisher","first-page":"636545","DOI":"10.3389\/fnagi.2021.636545","volume":"13","author":"T Shen","year":"2021","unstructured":"Shen T, Yue Y, He T et al (2021) The association between the gut microbiota and Parkinson\u2019s disease, a meta-analysis. Front Aging Neurosci 13:636545. https:\/\/doi.org\/10.3389\/fnagi.2021.636545","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"2292_CR77","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.3390\/ijms23052577","volume":"23","author":"DJ Vesga-Jim\u00e9nez","year":"2022","unstructured":"Vesga-Jim\u00e9nez DJ, Martin C, Barreto GE, Aristiz\u00e1bal-Pach\u00f3n AF, Pinz\u00f3n A, Gonz\u00e1lez J (2022) Fatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic Potential. Int J Mol Sci 23(5):2577","journal-title":"Int J Mol Sci"},{"key":"2292_CR78","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810248","author":"S van Voet","year":"2019","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201810248","journal-title":"EMBO Mol Med"},{"issue":"16","key":"2292_CR79","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1128\/AEM.00062-07","volume":"73","author":"Q Wang","year":"2007","unstructured":"Wang Q, Garrity GM, Tiedje JM, Cole JR (2007) Na\u00efve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73(16):5261\u20135267. https:\/\/doi.org\/10.1128\/AEM.00062-07","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"2292_CR80","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cells8010027","volume":"8","author":"H Xicoy","year":"2019","unstructured":"Xicoy H, Wieringa B, Martens GJM (2019) The role of lipids in Parkinson\u2019s disease. Cells 8(1):27","journal-title":"Cells"},{"issue":"7","key":"2292_CR81","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s11011-022-01004-6","volume":"37","author":"Z Yan","year":"2022","unstructured":"Yan Z, Li R, Shi W, Yao L (2022) Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson\u2019s Disease. Metab Brain Dis 37(7):2511\u20132520. https:\/\/doi.org\/10.1007\/s11011-022-01004-6","journal-title":"Metab Brain Dis"},{"key":"2292_CR82","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.csbj.2023.03.017","volume":"21","author":"D Yang","year":"2023","unstructured":"Yang D, Wang Z, Chen Y, Guo Q, Dong Y (2023) Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis. Comput Struct Biotechnol J 21:2215\u20132227. https:\/\/doi.org\/10.1016\/j.csbj.2023.03.017","journal-title":"Comput Struct Biotechnol J"},{"issue":"Pt 2","key":"2292_CR83","doi-asserted-by":"publisher","first-page":"137373","DOI":"10.1016\/j.ijbiomac.2024.137373","volume":"283","author":"X Yang","year":"2024","unstructured":"Yang X, Zhang X, Ma Y et al (2024) Fucoidan ameliorates rotenone-induced Parkinsonism in mice by regulating the microbiota-gut-brain axis. Int J Biol Macromol 283(Pt 2):137373. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137373","journal-title":"Int J Biol Macromol"},{"key":"2292_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-026-05181-4","author":"C Yang","year":"2026","unstructured":"Yang C, Li Y, Liu T et al (2026) Icaritin ameliorates MPTP-induced Parkinson\u2019s disease model by targeting the NLRP3 inflammasome pathway. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-026-05181-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"2292_CR85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/jnc.13575","volume":"137","author":"JJ Yerbury","year":"2016","unstructured":"Yerbury JJ, Ooi L, Dillin A et al (2016) Walking the tightrope: proteostasis and neurodegenerative disease. J Neurochem 137(4):489\u2013505. https:\/\/doi.org\/10.1111\/jnc.13575","journal-title":"J Neurochem"},{"key":"2292_CR86","doi-asserted-by":"publisher","first-page":"111262","DOI":"10.1016\/j.pnpbp.2025.111262","volume":"137","author":"N Zakaria","year":"2025","unstructured":"Zakaria N, Menze ET, Elsherbiny DA, Tadros MG, George MY (2025) Lycopene mitigates paclitaxel-induced cognitive impairment in mice; Insights into Nrf2\/HO-1, NF-kappaB\/NLRP3, and GRP-78\/ATF-6 axes. Prog Neuropsychopharmacol Biol Psychiatry 137:111262. https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111262","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"2292_CR87","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s13258-024-01491-0","volume":"46","author":"L Zeng","year":"2024","unstructured":"Zeng L, Ma J, Wei T et al (2024) The effect of canagliflozin on gut microbiota and metabolites in type 2 diabetic mice. Genes Genomics 46(5):541\u2013555. https:\/\/doi.org\/10.1007\/s13258-024-01491-0","journal-title":"Genes Genomics"},{"key":"2292_CR88","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.brainres.2016.11.020","volume":"1655","author":"Z-N Zhang","year":"2017","unstructured":"Zhang Z-N, Zhang J-S, Xiang J et al (2017) Subcutaneous rotenone rat model of Parkinson\u2019s disease: Dose exploration study. Brain Res 1655:104\u2013113. https:\/\/doi.org\/10.1016\/j.brainres.2016.11.020","journal-title":"Brain Res"},{"issue":"8","key":"2292_CR89","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.3233\/JPD-223500","volume":"12","author":"K Zhang","year":"2022","unstructured":"Zhang K, Paul KC, Jacobs JP et al (2022) Parkinson\u2019s disease and the gut microbiome in rural California. J Parkinson\u2019s Disease 12(8):2441\u20132452. https:\/\/doi.org\/10.3233\/JPD-223500","journal-title":"J Parkinson\u2019s Disease"},{"issue":"1","key":"2292_CR90","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao X-q et al (2021) Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9(1):226\u2013226. https:\/\/doi.org\/10.1186\/s40168-021-01107-9","journal-title":"Microbiome"},{"issue":"8","key":"2292_CR91","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/foods14081294","volume":"14","author":"S Zhou","year":"2025","unstructured":"Zhou S, Liu G, Wang Z, Lei Z, Chen W, Wang C (2025) Physiological benefits, applications, and future directions of \u03b2-hydroxy-\u03b2-methylbutyrate (HMB) in food and health industries. Foods 14(8):1294","journal-title":"Foods"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02292-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:16:41Z","timestamp":1784704601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02292-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2292"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02292-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}